Literature DB >> 11995186

[Bone grafts using tissue engineering].

C Delloye1.   

Abstract

An overview of bone grafts and, in particular, the allografts is presented. The availability of bone allografts, has promoted their use at the expense of the autograft. However, the loss of the cellular activity in an allograft, makes them less performant than an autograft. The use of an allograft in a small size defect can be advocated provided that the implantation technique is stringent. In case of a large segmental bone defect, an allograft can be considered whereas an autograft is not anymore possible. A massive bone allograft allows an anatomical reconstruction and the preservation of strong tendon insertions. In tumor surgery, a bone allograft has become one of the best options to reshape the skeleton. To offset the poor remodeling of the massive bone allografts, and to improve the take of small size bone allografts, researches are presently carried on, using tissue engineering in order to recover a cellular population. The aim is to combine an acellular bone graft with the cells of the recipient. Cells are procured from the bone marrow. Stromal cells are isolated, cultured, so that they will grow with an osteoblastic phenotype. They can be used alone or in association with a bone graft. It is believed that tomorrow such cellular therapy will become a routine procedure.

Entities:  

Mesh:

Year:  2001        PMID: 11995186

Source DB:  PubMed          Journal:  Bull Mem Acad R Med Belg        ISSN: 0377-8231


  4 in total

1.  Repair of segmental ulnar bone defect in juvenile caused by osteomyelitis with induced membrane combined with tissue-engineered bone: A case report with 4-year follow-up.

Authors:  Yang Gao; Jiangang Cheng; Zhuoyu Long; Pengzhen Cheng; Shuaishuai Zhang; Guoxian Pei; Zhengyu Li; Guolin Meng
Journal:  Int J Surg Case Rep       Date:  2022-08-31

Review 2.  Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering.

Authors:  Gabriela Fernandes; Shuying Yang
Journal:  Bone Res       Date:  2016-12-13       Impact factor: 13.567

3.  Reprogramming of Mouse Calvarial Osteoblasts into Induced Pluripotent Stem Cells.

Authors:  Yinxiang Wang; Jessica Aijia Liu; Keith K H Leung; Mai Har Sham; Danny Chan; Kathryn S E Cheah; Martin Cheung
Journal:  Stem Cells Int       Date:  2018-03-12       Impact factor: 5.443

4.  Cytokine, Chemokine, and Growth Factor Profile Characterization of Undifferentiated and Osteoinduced Human Adipose-Derived Stem Cells.

Authors:  F Mussano; T Genova; M Corsalini; G Schierano; F Pettini; D Di Venere; S Carossa
Journal:  Stem Cells Int       Date:  2017-05-10       Impact factor: 5.443

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.